NO952366D0 - Dolostatin-analog - Google Patents

Dolostatin-analog

Info

Publication number
NO952366D0
NO952366D0 NO952366A NO952366A NO952366D0 NO 952366 D0 NO952366 D0 NO 952366D0 NO 952366 A NO952366 A NO 952366A NO 952366 A NO952366 A NO 952366A NO 952366 D0 NO952366 D0 NO 952366D0
Authority
NO
Norway
Prior art keywords
dolostatin
analog
novel
chdcheco
formula
Prior art date
Application number
NO952366A
Other languages
English (en)
Norwegian (no)
Other versions
NO952366L (no
Inventor
Andreas Haupt
Bernd Janssen
Kurt Ritter
Dagmar Klinge
Gerhard Keilhauer
Cynthia Romerdahl
Teresa Barlozzari
Xiao-Dong Qian
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO952366D0 publication Critical patent/NO952366D0/no
Publication of NO952366L publication Critical patent/NO952366L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Window Of Vehicle (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO952366A 1992-12-16 1995-06-15 Dolostatin-analog NO952366L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99130992A 1992-12-16 1992-12-16
PCT/EP1993/003410 WO1994013695A1 (en) 1992-12-16 1993-12-04 Dolostatin analog

Publications (2)

Publication Number Publication Date
NO952366D0 true NO952366D0 (no) 1995-06-15
NO952366L NO952366L (no) 1995-06-15

Family

ID=25537082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952366A NO952366L (no) 1992-12-16 1995-06-15 Dolostatin-analog

Country Status (24)

Country Link
US (1) US5502032A (cs)
EP (1) EP0674652B1 (cs)
JP (1) JPH08504415A (cs)
CN (1) CN1057095C (cs)
AT (1) ATE196296T1 (cs)
AU (1) AU679479B2 (cs)
BR (1) BR1100019A (cs)
CA (1) CA2151953A1 (cs)
CZ (1) CZ286752B6 (cs)
DE (1) DE69329425T2 (cs)
ES (1) ES2151921T3 (cs)
FI (1) FI952961A0 (cs)
HR (1) HRP931504B1 (cs)
HU (1) HUT72067A (cs)
IL (1) IL107987A (cs)
NO (1) NO952366L (cs)
NZ (1) NZ258882A (cs)
PL (1) PL178766B1 (cs)
RU (1) RU2132334C1 (cs)
SG (1) SG67935A1 (cs)
SI (1) SI9300661A (cs)
TW (1) TW400335B (cs)
WO (1) WO1994013695A1 (cs)
ZA (1) ZA939389B (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599902A (en) * 1994-11-10 1997-02-04 Arizona Board Of Regents Acting On Behalf Of Arizona State University Cancer inhibitory peptides
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US5741892A (en) * 1996-07-30 1998-04-21 Basf Aktiengesellschaft Pentapeptides as antitumor agents
US5939527A (en) * 1996-07-30 1999-08-17 Basf Aktiengesellschaft Tetrapeptides as antitumor agents
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en) 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6297233B1 (en) 1999-02-09 2001-10-02 Bristol-Myers Squibb Company Lactam inhibitors of FXa and method
US6323315B1 (en) 1999-09-10 2001-11-27 Basf Aktiengesellschaft Dolastatin peptides
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
HUP0304058A2 (hu) 2001-01-30 2004-04-28 Bristol-Myers Squibb Company Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
US20050065118A1 (en) * 2001-10-16 2005-03-24 Jing Wang Organosulfur inhibitors of tyrosine phosphatases
WO2003075853A2 (en) 2002-03-08 2003-09-18 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
CA2524511A1 (en) * 2003-05-12 2004-11-18 Pfizer Products Inc. Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
EP1765332A2 (en) * 2004-06-17 2007-03-28 Cengent Therapeutics, Inc. Trisubstituted nitrogen modulators of tyrosine phosphatases
WO2006017124A2 (en) * 2004-07-09 2006-02-16 Cengent Therapeutics, Inc. Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases
WO2006028970A1 (en) 2004-09-02 2006-03-16 Cengent Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
JP5171621B2 (ja) 2005-07-07 2013-03-27 シアトル ジェネティックス， インコーポレイテッド フェニルアラニン側鎖修飾をｃ末端に有するモノメチルバリン化合物
CA2837840C (en) 2011-06-10 2020-08-04 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
WO2014093379A1 (en) 2012-12-10 2014-06-19 Mersana Therapeutics, Inc. Auristatin compounds and conjugates thereof
US9522876B2 (en) 2013-03-15 2016-12-20 Zymeworks Inc. Cytotoxic and anti-mitotic compounds, and methods of using the same
SG11201605260VA (en) 2013-12-27 2016-07-28 Zymeworks Inc Var2csa-drug conjugates
ES2916722T3 (es) 2013-12-27 2022-07-05 Zymeworks Inc Sistemas de enlace que contienen sulfonamida para conjugados de fármacos
EP3194421B1 (en) 2014-09-17 2021-11-03 Zymeworks Inc. Cytotoxic and anti-mitotic compounds, and methods of using the same
US10517958B2 (en) 2016-10-04 2019-12-31 Zymeworks Inc. Compositions and methods for the treatment of platinum-drug resistant cancer
EP4400121A1 (en) 2021-09-03 2024-07-17 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3540495A1 (de) * 1985-11-15 1987-05-21 Merck Patent Gmbh Aminosaeurederivate
ATE94395T1 (de) * 1986-05-09 1993-10-15 Pulverer Gerhard Verwendung von spezifischen monosacchariden zur herstellung eines arzneimittels zur verhinderung von metastasen maligner tumore.
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
JP2714402B2 (ja) * 1988-07-13 1998-02-16 日清製粉株式会社 癌転移抑制剤
DK414389A (da) * 1988-08-24 1990-02-26 Merck & Co Inc Farmaceutisk praeparat indeholdende et aminosyrederivat med renin-inhibitorisk virkning
US4978744A (en) * 1989-01-27 1990-12-18 Arizona Board Of Regents Synthesis of dolastatin 10
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
US5138036A (en) * 1989-11-13 1992-08-11 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
SG87056A1 (en) * 1991-08-09 2002-03-19 Teikoku Hormone Mfg Co Ltd Novel tetrapeptide derivative

Also Published As

Publication number Publication date
AU679479B2 (en) 1997-07-03
PL309353A1 (en) 1995-10-02
TW400335B (en) 2000-08-01
HUT72067A (en) 1996-03-28
EP0674652B1 (en) 2000-09-13
US5502032A (en) 1996-03-26
FI952961A7 (fi) 1995-06-15
RU95115135A (ru) 1997-06-10
ES2151921T3 (es) 2001-01-16
CN1095724A (zh) 1994-11-30
EP0674652A1 (en) 1995-10-04
FI952961L (fi) 1995-06-15
CN1057095C (zh) 2000-10-04
ZA939389B (en) 1995-06-15
SI9300661A (en) 1994-06-30
CZ286752B6 (en) 2000-06-14
JPH08504415A (ja) 1996-05-14
CZ157595A3 (en) 1996-01-17
IL107987A (en) 1999-10-28
HU9501754D0 (en) 1995-08-28
NZ258882A (en) 1997-06-24
AU5695994A (en) 1994-07-04
SG67935A1 (en) 1999-10-19
HRP931504A2 (en) 1997-02-28
CA2151953A1 (en) 1994-06-23
WO1994013695A1 (en) 1994-06-23
DE69329425T2 (de) 2001-01-18
PL178766B1 (pl) 2000-06-30
FI952961A0 (fi) 1995-06-15
HRP931504B1 (en) 2001-04-30
NO952366L (no) 1995-06-15
RU2132334C1 (ru) 1999-06-27
IL107987A0 (en) 1994-04-12
BR1100019A (pt) 2000-07-25
DE69329425D1 (de) 2000-10-19
ATE196296T1 (de) 2000-09-15

Similar Documents

Publication Publication Date Title
DE69329425D1 (de) Dolastatin analog
MY124487A (en) Dolastatin derivatives, their preparation and use
DK0642530T3 (da) Dolastatinderivater
NO954328D0 (no) Nye substituerte 1-fenyl-pyridinyl-benzotriazoler
MX9203100A (es) Nuevos peptidos, su preparacion y su aplicacion.
ES2104682T3 (es) Fluor-compuestos.
DK0601117T3 (da) Syntetiske tRNA'er
ES2098338T3 (es) Heteroarilmetilbencenos.
TR199701298T1 (xx) Tetralinler.
DK242089D0 (da) Anvendelse af pyrimido oe6,1-aaa-isoquinolin-4-on-derivater til hindring af haaraffald og foroegelse af haarvaekst
MY114327A (en) Novel peptides, the preparation and use thereof
FR2657879B1 (fr) Plaque de culture cellulaire.
BR9407232A (pt) Compostos de tiocarbamoíla
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
AU4863993A (en) Tetrahydroindazolone pharmaceutical compositions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application